Effect of Angiotensin Receptor Blockers on Cardiovascular Events in Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Trial

Nakai, 2004, An overview of dialysis treatment in Japan (as of Dec. 31, 2002), J Jpn Soc Dial Ther, 37, 1, 10.4009/jsdt.37.1 Weiner, 2006, Cardiovascular outcomes and all-cause mortality: Exploring the interaction between CKD and cardiovascular disease, Am J Kidney Dis, 48, 392, 10.1053/j.ajkd.2006.05.021 Ritz, 2004, Overview: Increased cardiovascular risk in patients with minor renal dysfunction: An emerging issue with far-reaching consequences, J Am Soc Nephrol, 15, 513, 10.1097/01.ASN.0000115398.92270.30 Tonelli, 2006, Chronic kidney disease and mortality risk: A systematic review, J Am Soc Nephrol, 17, 2034, 10.1681/ASN.2005101085 Suzuki, 2004, Angiotensin type 1 receptor blockers in chronic kidney disease, Contrib Nephrol, 143, 159, 10.1159/000078719 Dzau, 2005, The cardiovascular continuum and renin-angiotensin-aldosterone system blockade, J Hypertens Suppl, 23, S9, 10.1097/01.hjh.0000165623.72310.dd Eisenberg, 2006, Angiotensin II receptor blockers in congestive heart failure, Cardiol Rev, 14, 26, 10.1097/01.crd.0000182409.91935.85 Nakamura, 2005, An angiotensin receptor blocker reduces the risk of congestive heart failure in elderly hypertensive patients with renal insufficiency, Hypertens Res, 28, 415, 10.1291/hypres.28.415 Kanno, 2006, Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors, Clin J Am Soc Nephrol, 1, 730, 10.2215/CJN.01110905 Zannad, 2006, Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies, Kidney Int, 70, 1318, 10.1038/sj.ki.5001657 Signorini, 1993, Dynamic balanced randomization for clinical trials, Stat Med, 12, 2343, 10.1002/sim.4780122410 Hunt, 2001, Circulation, 104, 2996, 10.1161/hc4901.102568 Weber, 2003, Angiotensin II receptor blockers and cardiovascular outcomes: What does the future hold?, J Renin Angiotensin Aldosterone Syst, 4, 62, 10.3317/jraas.2003.015 Takahashi, 2006, Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis—A randomized study, Nephrol Dial Transplant, 21, 2507, 10.1093/ndt/gfl293 Zhang, 2006, Blood pressure lowering for primary and secondary prevention of stroke, Hypertension, 48, 187, 10.1161/01.HYP.0000231939.40959.60 Efrati, 2002, ACE inhibitors and survival of hemodialysis patients, Am J Kidney Dis, 40, 1023, 10.1053/ajkd.2002.36340 Laverman, 2002, Dual renin-angiotensin system blockade at optimal doses for proteinuria, Kidney Int, 62, 1020, 10.1046/j.1523-1755.2002.00536.x Wolf, 2005, Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications, Kidney Int, 67, 799, 10.1111/j.1523-1755.2005.00145.x Suzuki, 2004, Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy, Ther Apher Dial, 8, 320, 10.1111/j.1526-0968.2004.00142.x Takenaka, 2004, Pulse wave velocity as an indicator of arteriosclerosis in hemodialysis patients, Atherosclerosis, 176, 405, 10.1016/j.atherosclerosis.2004.05.024 Agarwal, 2002, Assessment of blood pressure in hemodialysis patients, Semin Dial, 15, 299, 10.1046/j.1525-139X.2002.00074.x Agarwal, 2003, Systolic hypertension in hemodialysis patients, Semin Dial, 16, 208, 10.1046/j.1525-139X.2003.16041.x Kalantar-Zadeh, 2003, Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients, Kidney Int, 63, 793, 10.1046/j.1523-1755.2003.00803.x Mazzuchi, 2000, Importance of blood pressure control in hemodialysis patient survival, Kidney Int, 58, 2147, 10.1111/j.1523-1755.2000.00388.x Chae, 1999, Increased pulse pressure and risk of heart failure in the elderly, JAMA, 281, 634, 10.1001/jama.281.7.634 Nichols, 2001, Congestive heart failure in type 2 diabetes: Prevalence, incidence, and risk factors, Diabetes Care, 24, 1614, 10.2337/diacare.24.9.1614 He, 2001, Risk factors for congestive heart failure in US men and women: NHANES I Epidemiologic Follow-up Study, Arch Intern Med, 161, 996, 10.1001/archinte.161.7.996 Gilbert, 2006, Heart failure and nephropathy: Catastrophic and interrelated complications of diabetes, Clin J Am Soc Nephrol, 1, 193, 10.2215/CJN.00540705 Khosla, 2006, Lessons learned from recent hypertension trials about kidney disease, Clin J Am Soc Nephrol, 1, 229, 10.2215/CJN.00840805